Santiago Rivera

Affiliations: 
Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France 
Google:
"Santiago Rivera"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Migliorati M, Manrique C, Rahrah M, et al. (2022) The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Pilat D, Paumier JM, García-González L, et al. (2022) MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65
Arnst N, Belio-Mairal P, García-González L, et al. (2021) Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes. Cells. 10
García-González L, Paumier JM, Louis L, et al. (2021) MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727
Zipfel P, Rochais C, Baranger K, et al. (2020) Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry
Rochais C, Lecoutey C, Hamidouche K, et al. (2019) Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology
García-González L, Pilat D, Baranger K, et al. (2019) Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244
Baranger K, van Gijsel-Bonnello M, Stephan D, et al. (2019) Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Rivera S, García-González L, Khrestchatisky M, et al. (2019) Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls
Rivera S. (2019) Metalloproteinases in nervous system function and pathology: introduction. Cellular and Molecular Life Sciences : Cmls
See more...